Related Experiment Videos
Cardiac disease in diabetic patients with renal disease
1Hope Hospital, Department of Renal Medicine, Salford, UK.
Insights
Diabetic patients with end-stage renal disease (ESRD) face high cardiovascular risks and mortality. Managing hypertension and anemia is crucial for improving outcomes in this vulnerable population.
Area of Science:
- Nephrology
- Cardiology
- Diabetology
Background:
- Diabetes is a leading cause of end-stage renal disease (ESRD).
- Diabetic ESRD patients on dialysis have significantly elevated cardiovascular risks.
- These patients experience increased risks of ischemic events and hemodynamic overload.
Purpose of the Study:
- To highlight the heightened cardiovascular risks in diabetic ESRD patients.
- To identify key modifiable risk factors for intervention.
- To emphasize the need for a multidisciplinary approach.
Main Methods:
- Review of existing literature on diabetic ESRD patients.
- Analysis of cardiovascular risk factors including hypertension, anemia, hypercholesterolemia, and blood glucose.
- Assessment of mortality rates and cardiovascular complications.
Main Results:
- Diabetic ESRD patients exhibit higher mortality rates compared to non-diabetic ESRD patients.
- Hypertension and anemia are significant contributors to cardiovascular risk and mortality.
- Anemia is linked to left ventricular hypertrophy and increased mortality.
Conclusions:
- Hypertension and anemia represent critical targets for intervention in diabetic ESRD patients.
- A multidisciplinary strategy is essential for managing multiple cardiovascular risk factors.
- Optimizing management of hypercholesterolemia, hypertension, blood glucose, and anemia can improve patient outcomes.
Abstract:
Patients with diabetes represent an increasing proportion of end-stage renal disease (ESRD) patients. Cardiovascular risk, already formidable among patients on dialysis, is significantly higher among those who also have diabetes. Diabetic ESRD patients are not only at higher risk of ischaemic events, but are also subject to haemodynamic overload, because of anaemia, hypertension, and arteriovenous dialysis connections. Mortality rates are also significantly higher in these patients. Hypertension and anaemia stand out as opportunities for intervention in these patients. Anaemia per se is associated with an increased risk of cardiovascular abnormalities, including left ventricular hypertrophy, and with an increased risk of mortality. The interplay of multiple risk factors in diabetic patients with ESRD demands a multidisciplinary approach for the early identification and management of cardiovascular risk factors--hypercholsterolaemia, hypertension, blood glucose and anaemia--in order to optimise outcomes in these patients.